Immune Design Corp., of Seattle, named Guy F. Cipriani chief business officer...Medivir AB, of Huddinge, Sweden, appointed Maris Hartmanis president and CEO

Elevation Pharmaceuticals Inc., of San Diego, appointed Jaisim Shah senior vice president and chief business officer and named Pravin Soni senior vice president and chief technical officer

Anaptys Bio Inc., of San Diego, named Carol G. Gallagher executive chair and promoted Hamza Suria to chief business officer and acting CEO

Silence Therapeutics plc, of London, appointed Thomas Christely CEO and named Tony Sedgwick chief business officer

and Alan W. Dunton as consulting chief medical officer...Medivir AB, of Huddinge, Sweden, made several recent appointments, including Maris Hartmanis as deputy CEO and chief operating officer...and Jens D. Kristensen as executive vice president of clinical

Alvine Pharmaceuticals Inc., of San Carlos, Calif., appointed James D. Watson senior vice president and chief business officer...and Alexander H. Burgess as vice president of marketing

Ascletis Inc., of Research Triangle Park, N.C., and Hangzhou, China, appointed Allan Baxter chief strategy officer...Celldex Therapeutics Inc., of Needham, Mass., appointed Ronald A. Pepin senior vice president and chief business officer

It also named Patrick Hwu and Mario Sznol to its recently formed scientific and medical advisory board and named Martin Schroeder to its board

OncoSec Medical Inc., of San Diego, appointed Michael Cross chief business officer, Caryn Peterson vice president of regulatory affairs and Veronica Vallejo controller and principal financial officer...Symphogen AG, of Copenhagen, Denmark, added Ivan D. Horak as chief scientific/medical officer and Gayle M. Mills as chief business officer

Neoprobe Corp., of Dublin, Ohio, appointed Mark Pykett president and CEO...Pepscan Therapeutics BV, of Lelystad, the Netherlands, appointed Michiel Lodder chief business officer...Trevena Inc., of King of Prussia, Pa., appointed Arthur Fratamico chief business officer

AlloCure Inc., of Burlington, Mass., appointed Kevin J. Heyeck chief business officer...It also added Michael Handelman as chief financial officer, treasurer and secretary...Medgenics Inc., of Misgav, Israel, added Isaac Blech and Raymond Dean Hautamaki to its board

Oncos Therapeutics, of Helsinki, Finland, appointed Jonathan Knowles and Robert Burns to its board...Topaz Pharmaceuticals Inc., of Horsham, Pa., appointed Mark Strobeck vice president and chief business officer

executive vice president and chief operating officer and named John A. Bellano senior vice president of sales and commercial programs

Markus Leyck Dieken senior vice president and general manager, Germany...and Manuela Maronati vice president, sales and marketing, Europe

OctoPlus NV, of Leiden, the Netherlands, named Jan Hendrik Egberts and nominated him for appointment as CEO...PolyTherics Ltd., of London, appointed John Burt chief business officer

Caprotec Bioanalytics GmbH, of Berlin, appointed Rainer Metternich managing director, chief business officer and chief operating officer...Cytogenix Inc., of New York, appointed Kevin Cassidy and Campbell Murray to its board...Intercell AG, of Vienna, Austria, named Staph Leavenworth Bakali chief business officer and appointed Eric Frings site director of Intercell Biomedical Ltd., of Livingston, Scotland

Probiodrug AG, of Halle, Germany, appointed Kumar Srinivasan chief business officer...Regenicin Inc., of New York, added Joseph Rubinfeld and Craig Eagle to its board

to chief operating officer and David R. Holland to senior vice president of sales and marketing...Genocea Biosciences, of Cambridge, Mass., appointed Chip Clark chief business officer

Hueneme, Calif., appointed Malcolm Gefter to its board and scientific advisory board...Vitae Pharmaceuticals Inc., of Fort Washington, Pa., named Christine Brennan chief business officer